About the research centre
The Research Centre for Molecular Cancer Prevention (RCMCP) is a research program for the discovery and implementation of molecular cancer prevention strategies.
We are based in the School of Molecular Sciences and collaborate with key local, national and international researchers and conduct multidisciplinary research.
Our objective is to lead innovative research and research training in molecular cancer prevention.
We do this by:
- integrating the expertise and capabilities at La Trobe University into new and innovative research programs, enabling molecular targeted cancer prevention therapies that benefit and impact society.
- providing cross-discipline education, training and career development opportunities in cancer prevention research and related skills.
Why study cancer prevention?
There is a 1 in 2 lifetime risk of developing cancer. Breast and prostate cancers are the most common cancers and by age 50, the majority of Australians will already carry silent, premalignant lesions .
Evidence-based economic and health burden studies show preventative approaches to cancer therapy are cost-effective and improve patient wellbeing. However, a major hurdle for new cancer prevention strategies is that we do not understand the biology of cancer initiation.
We need to develop new and improved preventative therapies, specifically designed to target the early biology of breast and prostate cancer. We also need to develop effective strategies for the uptake and implementation of promising molecular prevention therapies.